Blood Screening Market: Global Industry Trends, Growth Opportunities, and Forecast

The Blood Screening Market is expanding as healthcare systems place greater emphasis on transfusion safety, infectious disease detection, and advanced diagnostic technologies. Blood screening involves testing donated blood for transfusion-transmissible infections and other relevant markers before blood products are released for clinical use. The Market Research Future report covers technologies such as nucleic acid amplification testing, enzyme-linked immunosorbent assays, and next-generation sequencing, along with reagents and instruments.

Increasing blood donation volumes, stronger regulatory requirements, and growing awareness of blood safety are important factors supporting market development. Automation and integrated screening platforms are also transforming laboratory workflows by improving efficiency and reducing opportunities for manual errors.

Molecular testing technologies are gaining importance because they can help identify infections at earlier stages. Hospitals, blood banks, and clinical laboratories are increasingly adopting advanced screening systems to support reliable testing and efficient blood-product management.

According to Market Research Future, the market is projected to grow from USD 3.77 billion in 2026 to USD 8.19 billion by 2035, representing a 9.0% CAGR during the forecast period.